MX9204786A - Antagonistas del receptor 5-ht4 y composicion farmaceutica que los contiene. - Google Patents
Antagonistas del receptor 5-ht4 y composicion farmaceutica que los contiene.Info
- Publication number
- MX9204786A MX9204786A MX9204786A MX9204786A MX9204786A MX 9204786 A MX9204786 A MX 9204786A MX 9204786 A MX9204786 A MX 9204786A MX 9204786 A MX9204786 A MX 9204786A MX 9204786 A MX9204786 A MX 9204786A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- composition containing
- receptor antagonists
- antagonists
- receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919117943A GB9117943D0 (en) | 1991-08-20 | 1991-08-20 | Medicaments |
GB919119692A GB9119692D0 (en) | 1991-09-14 | 1991-09-14 | Pharmaceuticals |
GB929201414A GB9201414D0 (en) | 1992-01-23 | 1992-01-23 | Medicaments |
GB929203977A GB9203977D0 (en) | 1992-02-25 | 1992-02-25 | Pharmaceuticals |
GB929208321A GB9208321D0 (en) | 1992-04-15 | 1992-04-15 | Pharmaceuticals |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9204786A true MX9204786A (es) | 1993-04-01 |
Family
ID=27517068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9204786A MX9204786A (es) | 1991-08-20 | 1992-08-19 | Antagonistas del receptor 5-ht4 y composicion farmaceutica que los contiene. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0600955A1 (es) |
JP (1) | JPH06510283A (es) |
AU (2) | AU2435092A (es) |
CA (1) | CA2116024A1 (es) |
MX (1) | MX9204786A (es) |
NZ (1) | NZ243993A (es) |
PT (1) | PT100785A (es) |
WO (1) | WO1993003725A1 (es) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020128172A1 (en) | 1991-12-21 | 2002-09-12 | Smithkline Beecham Plc | Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases |
US5852014A (en) * | 1992-03-12 | 1998-12-22 | Smithkline Beecham P.L.C. | Condensed indole derivatives as 5HT4 -receptor antagonists |
US5998409A (en) * | 1992-03-12 | 1999-12-07 | Smithkline Beecham Plc | Condensed indole derivatives as 5HT4 -receptor antagonists |
AU4081393A (en) * | 1992-05-23 | 1993-12-30 | Smithkline Beecham Plc | Medicaments for the treatment of anxiety |
WO1994000113A2 (en) * | 1992-06-27 | 1994-01-06 | Smithkline Beecham Plc | Medicaments containing 5-ht4 receptor antagonists |
US5726187A (en) * | 1992-10-16 | 1998-03-10 | Smithkline Beecham Plc | N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists |
ES2056728B1 (es) * | 1992-10-28 | 1995-05-01 | Smithkline Beecham Plc | Nuevos derivados de piperidilo y aminoalquilo con actividad antagonista del receptor 5-ht4 |
AU680453B2 (en) * | 1992-11-05 | 1997-07-31 | Smithkline Beecham Plc | Piperidine derivatives as 5-HT4 receptor antagonists |
US6127379A (en) * | 1993-02-01 | 2000-10-03 | Smithkline Beecham P.L.C. | Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists |
GB9310582D0 (en) * | 1993-05-22 | 1993-07-07 | Smithkline Beecham Plc | Pharmaceuticals |
GB9312348D0 (en) * | 1993-06-16 | 1993-07-28 | Smithkline Beecham Plc | Pharmaceuticals |
FR2717174B1 (fr) * | 1994-03-14 | 1996-05-31 | Sanofi Sa | Utilisation de pipéridinoéthyl esters de l'acide 4-amino-5-chloro-2-méthoxybenzoïque comme 5-HT4 agonistes. |
WO1995025100A1 (fr) * | 1994-03-14 | 1995-09-21 | Sanofi | Utilisation d'esters de l'acide 4-amino-5-chloro-2-methoxybenzoique comme 5-ht4 agonistes |
EP0683161A1 (fr) * | 1994-05-17 | 1995-11-22 | MIDY S.p.A. | Nouvel ester de l'acide 4-amino-5-chloro-2-méthoxybenzoique, procédé pour sa préparation et compositions pharmaceutiques le contenant |
WO1996005166A1 (fr) * | 1994-08-11 | 1996-02-22 | Yamanouchi Pharmaceutical Co., Ltd. | Derive d'amine substitue et composition medicamenteuse le contenant |
JP3862750B2 (ja) * | 1994-09-27 | 2006-12-27 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | フェニル−オキソ−アルキル−(4−ピペリジニル)ベンゾエート誘導体 |
AU699152B2 (en) * | 1994-09-27 | 1998-11-26 | Janssen Pharmaceutica N.V. | N-substituted piperidinyl bicyclic benzoate derivatives |
US5654320A (en) * | 1995-03-16 | 1997-08-05 | Eli Lilly And Company | Indazolecarboxamides |
IL117438A (en) * | 1995-03-16 | 2001-12-23 | Lilly Co Eli | Indazolecarboxamides, their preparation and pharmaceutical compositions containing them |
WO1996038420A1 (fr) * | 1995-05-31 | 1996-12-05 | Nisshin Flour Milling Co., Ltd. | Derives de l'indazole a groupe amino monocyclique |
FR2741069B1 (fr) * | 1995-11-09 | 1997-12-12 | Synthelabo | Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h) -one, leur preparation et leur application en therapeutique |
PL186204B1 (pl) * | 1995-11-09 | 2003-11-28 | Sanofi Synthelabo | Pochodne 5-fenylo-3-(piperydyn-4-ylo)-1,3,4-oksadiazol-2(3H)-onu do stosowania jako ligandy receptora 5-HT lub H |
TW445263B (en) | 1996-02-29 | 2001-07-11 | Janssen Pharmaceutica Nv | Novel esters of 1,4-disubstituted piperidine derivatives |
IT1291569B1 (it) * | 1997-04-15 | 1999-01-11 | Angelini Ricerche Spa | Indazolammidi come agenti serotoninergici |
TW548103B (en) | 1997-07-11 | 2003-08-21 | Janssen Pharmaceutica Nv | Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
FR2766484B1 (fr) * | 1997-07-25 | 1999-09-17 | Logeais Labor Jacques | Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse |
US6069152A (en) * | 1997-10-07 | 2000-05-30 | Eli Lilly And Company | 5-HT4 agonists and antagonists |
CA2340952C (en) * | 1998-09-10 | 2009-12-08 | F. Hoffmann-La Roche Ag | Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists |
TR200101398T2 (tr) * | 1998-11-20 | 2001-09-21 | F.Hoffmann-La Roche Ag | Pirolidin türevleri-CCR-3 reseptörü antagonistleri. |
TW570920B (en) | 1998-12-22 | 2004-01-11 | Janssen Pharmaceutica Nv | 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
FR2821356A1 (fr) | 2001-02-23 | 2002-08-30 | Cerep | Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations |
GB0211230D0 (en) | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
ITMI20031468A1 (it) | 2003-07-18 | 2005-01-19 | Acraf | Farmaco ativo nel dolore neuropatico |
TW200533348A (en) | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
TWI351282B (en) | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
US7728006B2 (en) | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
US7396933B2 (en) | 2004-11-05 | 2008-07-08 | Theravance, Inc. | Quinolinone-carboxamide compounds |
EP1807422B1 (en) | 2004-11-05 | 2009-09-02 | Theravance, Inc. | 5-ht4 receptor agonist compounds |
ATE469897T1 (de) | 2004-12-22 | 2010-06-15 | Theravance Inc | Indazolcarbonsäureamidverbindungen |
BRPI0608392A2 (pt) | 2005-03-02 | 2009-12-29 | Theravance Inc | compostos de quinolinona como agonistas do receptor 5-ht4 |
FR3006686A1 (fr) * | 2013-06-05 | 2014-12-12 | Univ Caen | Composes inhibiteurs de l'acetylcholinesterase et agonistes des recepteurs serotoninergiques 5ht4, a effet promnesiant, leurs procedes de preparation et compositions pharmaceutiques les contenant |
GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI74707C (fi) * | 1982-06-29 | 1988-03-10 | Sandoz Ag | Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror. |
DE3587151T2 (de) * | 1984-12-20 | 1993-07-15 | Sandoz Ag | Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten. |
EP0200444B1 (en) * | 1985-04-27 | 1992-11-11 | Beecham Group Plc | Azabicyclononyl-indazole-carboxamide having 5-ht antagonist activity |
CA2030051C (en) * | 1989-11-17 | 2001-08-07 | Haruhiko Kikuchi | Indole derivatives |
-
1992
- 1992-08-18 NZ NZ243993A patent/NZ243993A/en unknown
- 1992-08-18 JP JP5504191A patent/JPH06510283A/ja active Pending
- 1992-08-18 CA CA002116024A patent/CA2116024A1/en not_active Abandoned
- 1992-08-18 EP EP92917490A patent/EP0600955A1/en not_active Withdrawn
- 1992-08-18 PT PT100785A patent/PT100785A/pt not_active Application Discontinuation
- 1992-08-18 AU AU24350/92A patent/AU2435092A/en not_active Abandoned
- 1992-08-18 WO PCT/GB1992/001519 patent/WO1993003725A1/en not_active Application Discontinuation
- 1992-08-19 MX MX9204786A patent/MX9204786A/es unknown
-
1996
- 1996-04-29 AU AU51944/96A patent/AU5194496A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NZ243993A (en) | 1994-10-26 |
EP0600955A1 (en) | 1994-06-15 |
JPH06510283A (ja) | 1994-11-17 |
WO1993003725A1 (en) | 1993-03-04 |
PT100785A (pt) | 1994-04-29 |
CA2116024A1 (en) | 1993-03-04 |
AU2435092A (en) | 1993-03-16 |
AU5194496A (en) | 1996-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9204786A (es) | Antagonistas del receptor 5-ht4 y composicion farmaceutica que los contiene. | |
MX9202546A (es) | Dimeros de rapamicina y composicion farmaceutica que los contiene. | |
MX9205345A (es) | Alquil-bisacilfosfinoxidos y composicion que contienen los mismos. | |
DE69101931D1 (de) | Pharmazeutische Zusammensetzung. | |
DE68901417D1 (de) | Pharmazeutische zusammensetzung. | |
ATA129892A (de) | Pharmazeutische zusammensetzung | |
DE3486255T2 (de) | Pharmazeutische Zusammensetzungen. | |
DE69207351T2 (de) | Fibrinogen-Rezeptor-Antagoniste | |
DE3483133D1 (de) | Pharmazeutische zusammensetzungen. | |
MX9203027A (es) | Derivados heterociclicos de acilaminotiazoles y composicines farmaceuticas que los contienen. | |
DE69222006D1 (de) | Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten | |
NO923127L (no) | Farmasoeytisk kombinasjonsformulering | |
DE69115263D1 (de) | Pharmazeutische zusammensetzungen. | |
DE3485408D1 (de) | Pharmazeutische zusammensetzung. | |
DE3484098D1 (de) | Pharmazeutische zusammensetzungen. | |
DE69006094D1 (de) | Pharmazeutische Zusammensetzungen. | |
MX9102500A (es) | Compuestos de bifenilio, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
MX9201710A (es) | Carbamatos de rapamicina y composicion farmaceutica que los contiene. | |
MX9204563A (es) | Nuevos derivados de la (2-alquil-3-piridil)-metilpiperazina y composicion farmaceutica que los comprende. | |
IT8820386A0 (it) | Composizioni farmaceutiche orosolubili contenti acetilcisteina. | |
MX9202152A (es) | Derivados del indol, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
FI893643A (fi) | Farmaceutiska kompositioner. | |
MX9201847A (es) | Derivados heterociclicos de antiserotoninas, procedimiento para su preparacion y medicamentos que los contienen. | |
MX9206073A (es) | Nuevos compuestos antagonistas del receptor 5-hidroxitriptamina y composiciones farmaceuticas que los contienen | |
MX9203732A (es) | R-enentiomeros de compuestos de n-propargil-1-aminoindan, su preparacion y composiciones farmaceuticas que contienen los mismos. |